MENU
AUG 30, 2016 8:00 AM PDT

Exploring new avenues for cataract treatment using human pluripotent stem cells

Speaker
  • Director, Molecular Medicine Research Group, Western Sydney University, Australia, Senior Lecturer, School of Medicine, Western Sydney University, Australia Honorary Senior Lecturer, Save S
    Biography
      Michael uses human pluripotent cells to model macular degeneration and cataract. He received his PhD from the University of Sydney in 2005, regenerating and characterising functional ocular lenses in vitro. During postdoctoral studies in Vancouver, Canada, he identified genes related to pluripotency and played a key role in the commercial development of mTeSR1 and TeSR2 with Stem Cell Technologies. As the current President of the Australasian Society for Stem Cell Research he has developed a touring stem cell art exhibition, seen by over 1 million people, that stimulates public discussion on emerging stem cell therapies.

    Abstract
    Cataract, or vision loss due to clouding of the eye’s lens, is a large and costly international problem. Over 80 million people currently have low vision due to cataract. Cataracts can only be treated surgically, and while this restores vision the ability to focus between near and far objects is lost. Cataract surgery is the most commonly performed ophthalmic procedure and globally costs tens of billions of dollars annually. Due to population aging the incidence of cataract is increasing, and so are the associated costs. It has been estimated that a 10-year delay in cataract formation could halve the number and costs of cataract surgery. To address this issue Dr O’Connor has developed a world-first method to produce large numbers of human lens cells from pluripotent stem cells. The ability to access unlimited numbers of human lens cells, for defining cataract risk factors and performing anti-cataract drug screening, represents a true paradigm shift in international cataract research.
     

    Show Resources
    You May Also Like
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    DEC 09, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 09, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 09, 2020 TIME: 09:00am PDT Hematopoietic stem cells (HSCs) ensure homeostasis of blood throughout life. In this webinar, we share insights into the smart and easy isolation, c...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    AUG 18, 2020 10:00 AM PDT
    C.E. CREDITS
    AUG 18, 2020 10:00 AM PDT
    DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
    Loading Comments...
    Show Resources
    Attendees
    • See more